Toxins 2016, 8(2), 51; https://doi.org/10.3390/toxins8020051
Long-Term Blood Pressure Control Effect of Celiac Plexus Block with Botulinum Toxin
1
Department of Anaesthesiology & Pain Medicine, Seoul St. Mary’s Hospital, College of Medicine, The Catholic University of Korea, Seoul 06591, Korea
2
Division of Cardiology, Department of Internal Medicine, Seoul St. Mary’s Hospital, College of Medicine, The Catholic University of Korea, Seoul 06591, Korea
*
Author to whom correspondence should be addressed.
Academic Editor: Bahman Jabbari
Received: 31 December 2015 / Revised: 31 January 2016 / Accepted: 14 February 2016 / Published: 19 February 2016
(This article belongs to the Section Bacterial Toxins)
Abstract
Celiac plexus block (CPB) is one of the main treatment options for patients resistant to conventional antihypertensive drugs. We present a case of resistant hypertension (RHTN) that was treated with CPB using botulinum toxin. An 18-year-old male patient with RHTN, who suffered from persistent hypertension even after combination therapy and a renal denervation procedure, was referred to our pain center for CPB. CPB using botulinum toxin following the use of only local anesthetics resulted in control of systolic blood pressure (BP) at ~150 mmHg for at least three months. View Full-TextKeywords:
celiac plexus block; resistant hypertension; botulinum toxin
▼
Figures
Figure 1
This is an open access article distributed under the Creative Commons Attribution License which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited (CC BY 4.0).
Share & Cite This Article
MDPI and ACS Style
Lee, S.H.; Lim, D.H.; Lee, J.H.; Chang, K.; Koo, J.M.; Park, H.J. Long-Term Blood Pressure Control Effect of Celiac Plexus Block with Botulinum Toxin. Toxins 2016, 8, 51.
Note that from the first issue of 2016, MDPI journals use article numbers instead of page numbers. See further details here.